عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Drugs Public Price List 2016

Drugs Prices According to the Exchange Rate Issued on 9/12/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016   (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016  (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016 
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016 .
 
Drugs Prices According to the Exchange Rate Issued on 1/12/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016.
 
Drugs Prices According to the Exchange Rate Issued on 11/11/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016.
 
Drugs Prices According to the Exchange Rate Issued on 1/11/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016.
 
Drugs Prices According to the Exchange Rate Issued on 17/10/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016.
    1
    ...
    104
    105
    106
    107
    108
    109
    ...
    201
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
J07BC02 VAQTA B Hepatitis A, inactivated, whole virus - 25U/0.5ml 25U/0.5ml Injectable suspension 2,539,862 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose 0.5ml/dose Injectable suspension 1,777,904 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose 0.5ml/dose Injectable suspension 2,257,655 L.L
J07BD52 PRIORIX B Rubella virus live attenuated - ?10³ CCID50, Mumps virus live attenuated - ?103.7 CCID50, Measles virus live attenuated - ?10³ CCID50 Injectable lyophilised powder for solution+diluent 1,142,266 L.L
J07BD52 M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE) B Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated - Injectable solution+diluent 12,924,401 L.L
J07BD52 MEASLES, MUMPS AND RUBELLA VACCINE LIVE ATTENUATED (FREEZE-DRIED) MMR G Rubella virus live attenuated - ?1000CCID50 /0.5ml, Mumps virus live attenuated - ?5000CCID50 /0.5ml, Measles virus live attenuated - ?1000CCID50 /0.5ml Injectable freeze dried powder + diluent 537,537 L.L
J07BD54 PROQUAD VACCINE BioTech Measles virus live attenuated - ?3.00 log10 TCID50 , Mumps virus live attenuated - ?4.30 log10 TCID50 , Rubella virus live attenuated - ?3.00 log10 TCID50 , Varicella virus, live attenuated - ?3.00 log10 PFU Injectable lyophilised powder 12,146,465 L.L
J07BF03 POLIOMYELITIS VACCINE INACTIVATED B Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U Injectable suspension 1,206,771 L.L
J07BG01 RABIVAX-S (RABIES VACCINE INACTIVATED) BioTech Freeze dried inactivated purified rabies antigen (Pitman Moore PM3218 as virus strain) - Injectable freeze dried material 1,552,138 L.L
J07BH01 ROTATEQ ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT B Rotavirus G1, live attenuated - ?2.2x106 IU, Rotavirus G2, live attenuated - ?2.8x106 IU, Rotavirus G3, live attenuated - ?2.2x106 IU, Rotavirus G4, live attenuated - ?2.0x106 IU, Rotavirus P1, live attenuated - ?2.3x106 IU Suspension 4,508,592 L.L
J07BH01 ROTARIX ORAL B Rota virus human RIX4414, live attenuated - ?106 CCID50 Suspension 5,167,074 L.L
J07BH01 ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED) BioTech Rotavirus bovine-human , live attenuated - Suspension 2,822,069 L.L
J07BH01 ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID) BioTech Rotavirus bovine-human , live attenuated - Liquid 2,822,069 L.L
J07BK01 VARILRIX + SOLVENT IN SYRINGE B Varicella virus, live attenuated - ?1033 PFU ?1033 PFU Injectable lyophilised powder for solution+diluent 3,473,833 L.L
J07BK01 VARIVAX B Varicella virus, live attenuated - 1350PFU Injectable powder for suspension+diluent 4,102,751 L.L
J07BK01 VARICELLA VACCINE LIVE BioTech Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated - Injectable suspension 3,104,276 L.L
J07BM03 GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT B Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml Injectable suspension 16,192,031 L.L
J07CA LANTIGEN B B Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml Drops suspension 952,784 L.L
J07CA02 TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé) B Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg Injectable suspension 1,628,737 L.L
J07CA06 INFANRIX IPV + HIB B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 3,014,239 L.L
J07CA06 PENTAXIM B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 2,558,676 L.L
J07CA09 INFANRIX HEXA B Diphteria toxoid purified (Prefilled syringe) - ?30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ?40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml Injectable suspension 4,230,416 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,509,935 L.L
J07CA11 DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE B Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein - Injectable suspension 1,515,854 L.L
L01AA01 ENDOXAN B Cyclophosphamide (monohydrate) - 500mg 500mg Injectable powder for solution 764,646 L.L
L01AA06 HOLOXAN B Ifosfamide - 1g 1g Injectable powder for solution 3,586,850 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE ACCORD G Bendamustine HCl - 25mg/10ml 25mg/10ml Injectable powder for concentrate for solution 11,186,776 L.L
L01AA09 BENDAMUSTINE MEDAC G Bendamustine HCl - 2.5mg/ml (25mg) 2.5mg/ml Injectable powder for concentrate for solution 10,405,803 L.L
L01AA09 RIBOMUSTIN B Bendamustine HCl - 100mg 100mg Injectable powder for concentrate for solution 34,377,547 L.L
L01AA09 BENDAMUSTINE HYDROCHLORIDE G Bendamustine HCl - 100mg/50ml 100mg/50ml Injectable powder for concentrate for solution 1,409,714 L.L
    1
    ...
    104
    105
    106
    107
    108
    109
    ...
    201
Sitemap
© Copyrights reserved to Ministry of Public Health 2024